Q9BYF1 (ACE2_HUMAN) Homo sapiens (Human)
Angiotensin-converting enzyme 2 UniProtKBInterProSTRINGInteractive Modelling
805 aa; Sequence (Fasta) ; (Isoform 3)
Models are currently being built for this target protein.
(Depending on server load, it will take approximately 15-30 minutes before the new models are available in SWISS-MODEL Repository)
Please note that SMR updates are performed with default parameters for template selection and quality filters. If you prefer to interactively explore various models build on different templates, please use SWISS-MODEL workspace.
Available Structures
299 Experimental Structures
Description | PDB ID | Oligo-state | Range | Seq id (%) | Ligands | |
---|---|---|---|---|---|---|
ACE2 -Targeting Monoclonal Antibody as Potent and Broad-Spectrum Coronavirus Blocker |
Heteromer Q695T7; | 100 | 14×NAG; 10×NAG; 2×ZN; | |||
Structure of human SIT1:ACE2 complex (open PD conformation) |
Heteromer Q9NP91; | 100 | 2×NAG; 2×NAG; 2×ZN; 2×NDG; 8×NAG; | |||
SIT1-ACE2-BA.2 RBD |
Heteromer P0DTC2; Q9NP91; | 100 | 16×NAG; 6×NAG; 6×3PH; 2×ZN; | |||
SIT1-ACE2-BA.5 RBD |
Heteromer P0DTC2; Q9NP91; | 100 | 16×NAG; 6×NAG; 6×3PH; 2×ZN; | |||
ACE2-SIT1 complex bound with proline |
Heteromer Q9NP91; | 100 | 14×NAG; 4×NAG; 2×ZN; 2×PRO; 2×CL; | |||
ACE2-B0AT1 complex bound with glutamine |
Heteromer Q695T7; | 100 | 14×NAG; 10×NAG; 2×ZN; 2×GLN; | |||
ACE2-B0AT1 complex |
Heteromer Q695T7; | 100 | 14×NAG; 10×NAG; 4×3PH; 2×ZN; | |||
Structure of human SIT1:ACE2 complex (closed PD conformation) |
Heteromer Q9NP91; | 100 | 2×NAG; 2×NAG; 2×ZN; 2×NDG; 12×NAG; | |||
Structure of human SIT1:ACE2 complex (closed PD conformation) bound to L-pipecolate |
Heteromer Q9NP91; | 100 | 2×NAG; 2×NAG; 2×ZN; 2×NDG; 12×NAG; 2×YCP; | |||
ACE2-B0AT1 complex bound with methionine |
Heteromer Q695T7; | 100 | 14×NAG; 10×NAG; 2×ZN; 2×MET; | |||
Cryo-EM structure of ACE2-B0AT1 complex with JX98 |
Heteromer Q695T7; | 100 | 14×NAG; 2×WM8; 2×NAG; | |||
Cryo-EM structure of ACE2-SIT1 complex with tiagabine |
Heteromer Q9NP91; | 99.87 | 12×NAG; 4×NAG; 2×TGI; | |||
Cryo-EM structure of ACE2-B0AT1 complex with JX225 |
Heteromer Q695T7; | 100 | 16×NAG; 6×NAG; 2×XF0; | |||
The 2019-nCoV RBD/ACE2-B0AT1 complex |
Heteromer P0DTC2; Q695T7; | 100 | 14×NAG; 2×NAG; 10×NAG; 2×LEU; 2×ZN; | |||
ACE2-B0AT1 complex, open conformation |
Heteromer Q695T7; | 100 | ||||
Structure of human SIT1:ACE2 complex (open PD conformation) bound to L-pipecolate |
Heteromer Q9NP91; | 100 | 2×NAG; 2×NAG; 2×ZN; 2×NDG; 12×NAG; 2×YCP; 2×CL; | |||
Conformation 1 of S-ACE2-B0AT1 ternary complex |
Heteromer P0DTC2; Q695T7; | 100 | 58×NAG; 64×NAG; 2×LEU; 2×ZN; | |||
Cryo-EM structure of human ACE2 receptor bound to protein encoded by vaccine candidate BNT162b1 |
Heteromer P0DTC2; | 100 | ||||
The complex structure of RshSTT182/200 RBD bound to human ACE2 |
Heteromer | 100 | 5×NAG; 1×ZN; | |||
Structure of the human ACE2 receptor in complex with antibody Fab fragment, 05B04 |
Heteromer | 100 | 2×NAG; 1×NAG; 3×NAG; | |||
RBD of SARS-CoV2 spike protein with ACE2 decoy |
Heteromer P0DTC2; | 99.0 | 2×NAG; 2×NAG; 1×NAG; 1×NAG; 1×ZN; 1×SO4; | |||
Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2) |
Heteromer | 100 | 3×NAG; 1×CL; 1×ZN; | |||
Crystal structure of SARS-CoV-2 spike receptor-binding domain bound with ACE2 |
Heteromer P0DTC2; | 100 | 1×ZN; 1×CL; 5×NAG; | |||
Crystal structure of SARS-CoV-2 omicron RBD and human ACE2 |
Heteromer P0DTC2; | 100 | 1×NAG; 1×ZN; 1×CL; 4×NAG; | |||
Crystal structure of spike protein receptor-binding domain from a predicted SARS coronavirus human … |
Heteromer P59594; | 100 | 1×ZN; 1×CL; | |||
Structure of SARS coronavirus spike receptor-binding domain complexed with its receptor |
Heteromer P59594; | 100 | 1×NAG; 4×NAG; 1×ZN; 1×CL; | |||
Crystal structure of spike protein receptor-binding domain from a predicted SARS coronavirus civet … |
Heteromer P59594; | 100 | 1×ZN; 1×CL; | |||
Inhibitor Bound Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2) |
Heteromer | 100 | 2×NAG; 1×CL; 1×ZN; 1×XX5; | |||
Crystal structure of spike protein receptor-binding domain from a predicted SARS coronavirus civet … |
Heteromer P59594; Q56NL1; | 100 | 1×ZN; 1×CL; | |||
Crystal structure of spike protein receptor binding domain of escape mutant SARS-CoV-2 from immunoc… |
Heteromer P0DTC2; | 100 | 1×NAG; 2×NAG; 1×NAG; 1×NAG; 1×NAG; 1×ZN; 1×CL; 1×NAG; | |||
Crystal structure of spike protein receptor-binding domain from the 2002-2003 SARS coronavirus cive… |
Heteromer P59594; Q56NL1; | 100 | 5×NDG; 2×ZN; 2×CL; 1×NAG; | |||
Crystal structure of human ACE2 and GX/P2V RBD |
Heteromer A0A6G6A2Q2; | 100 | 1×ZN; | |||
Structure of SARS-CoV-2 spike receptor-binding domain complexed with high affinity ACE2 mutant 3N39 |
Heteromer P0DTC2; | 98.83 | 2×NAG; 2×NAG; 1×NAG; 1×NAG; 1×ZN; 1×SO4; | |||
Crystal structure of SARS-CoV-2 RBD Q498Y complexed with human ACE2 |
Heteromer P0DTC2; | 100 | 3×NAG; 1×ZN; 1×EDO; 1×CL; | |||
SARS-CoV-2 Omicron BA.2 RBD in complex with ACE2 |
Heteromer P0DTC2; | 100 | 6×NAG; 1×ZN; | |||
Crystal structure of affinity-enhancing and catalytically inactive ACE2 in complex with SARS-CoV-2 … |
Heteromer P0DTC2; | 99.16 | 6×NAG; 1×ZN; | |||
Receptor-binding domain (RBD) of the spike protein of the bat coronavirus RaTG13 virus in complex w… |
Heteromer | 100 | 2×NAG; 3×NAG; | |||
Receptor-binding domain (RBD) of the spike protein of the bat coronavirus RaTG13 virus in complex w… |
Heteromer | 100 | 2×NAG; 3×NAG; | |||
BA.2.86 RBD in complex with hACE2 (local refinement) |
Heteromer P0DTC2; | 100 | 1×ZN; 1×CL; 6×NAG; | |||
SARS-CoV-2 Delta S-RBD-ACE2 complex |
Heteromer P0DTC2; | 100 | ||||
SARS-CoV-2 Delta S-RBD-ACE2 |
Heteromer P0DTC2; | 100 | ||||
Cryo-EM structure of SARS-CoV2 RBD-ACE2 complex |
Heteromer P0DTC2; | 100 | 1×ZN; 1×CL; 5×NAG; | |||
Cryo-EM structure of SARS-CoV-2 Omicron spike protein with human ACE2 (focus refinement on RBD-1/AC… |
Heteromer P0DTC2; | 100 | ||||
Cryo-EM structure of human ACE2 and GX/P2V/2017 RBD |
Heteromer A0A6G6A2Q2; | 100 | 1×ZN; 5×NAG; | |||
SARS-COV-2 Spike RBDMACSp25 binding to hACE2 |
Heteromer P0DTC2; | 100 | 5×NAG; | |||
ACE2-RBD in SARS-CoV-2 Kappa variant S-ACE2 complex |
Heteromer P0DTC2; | 100 | 1×ZN; 5×NAG; | |||
SARS-CoV-2 Delta S-RBD-ACE2 |
Heteromer P0DTC2; | 100 | ||||
Cryo-EM structure of human ACE2 and GD/1/2019 RBD |
Heteromer A0A7D6PMV8; | 100 | 1×ZN; 4×NAG; | |||
Cryo-EM structure of Human ACE2 bound to a high-affinity SARS CoV-2 mutant |
Heteromer P0DTC2; | 100 | 3×NAG; | |||
S-ECD (Omicron BA.3) in complex with three PD of ACE2 |
Heteromer P0DTC2; | 100 | 38×NAG; 28×NAG; | |||
Trypsin-cleaved and low pH-treated SARS-CoV spike glycoprotein and ACE2 complex, ACE2-bound conform… |
Heteromer P59594; | 100 | ||||
S-RBD (Omicron BF.7) in complex with PD of ACE2 |
Heteromer P0DTC2; | 100 | 6×NAG; 1×NAG; | |||
SARS-CoV-2 Delta S-ACE2-C3 |
Heteromer P0DTC2; | 100 | ||||
S-ECD (Omicron BF.7) in complex with PD of ACE2 |
Heteromer P0DTC2; | 100 | 38×NAG; 28×NAG; | |||
SARS-CoV-2 Delta S-ACE2-C1 |
Heteromer P0DTC2; | 100 | ||||
Cryo-EM structure of SARS-CoV-2 Omicron Spike protein with human ACE2 receptor, C2 state |
Heteromer P0DTC2; | 100 | ||||
SARS-CoV-2 spike protein in complex with ACE2, Beta variant, C2B state |
Heteromer P0DTC2; | 100 | ||||
S-ECD (Omicron XBB.1) in complex with PD of ACE2 |
Heteromer P0DTC2; | 100 | 38×NAG; 28×NAG; | |||
Cryo-EM structure of Omicron S-ACE2, C2 state |
Heteromer P0DTC2; | 100 | ||||
SARS-CoV-2 S-ACE2 complex |
Heteromer P0DTC2; | 100 | 18×NAG; 36×NAG; | |||
Cryo-EM structure of SARS-CoV-2 Omicron Spike protein with human ACE2 receptor, C3 state |
Heteromer P0DTC2; | 100 | ||||
SARS-CoV-2 Delta S-ACE2-C2a |
Heteromer P0DTC2; | 100 | ||||
S-RBD(Omicron BA.3) in complex with PD of ACE2 |
Heteromer P0DTC2; | 100 | 6×NAG; 1×NAG; | |||
SARS-CoV-2 spike protein in complex with ACE2, Beta variant, C2A state |
Heteromer P0DTC2; | 100 | ||||
SARS-CoV-2 spike protein in complex with ACE2, Beta variant, C3 state |
Heteromer P0DTC2; | 100.0 | ||||
S-ECD (Omicron BA.3) in complex with two PD of ACE2 |
Heteromer P0DTC2; | 100 | 33×NAG; 27×NAG; | |||
SARS-CoV-2 spike protein in complex with ACE2, Beta variant, C1 state |
Heteromer P0DTC2; | 100 | ||||
SARS-CoV-2 Delta S-ACE2-C2b |
Heteromer P0DTC2; | 100 | ||||
S-ECD (Omicron BA.2.75) in complex with PD of ACE2 |
Heteromer P0DTC2; | 100 | 37×NAG; 29×NAG; | |||
SARS-CoV-2 Kappa variant spike protein in complex wth ACE2, state C1 |
Heteromer P0DTC2; | 100 | ||||
S-ECD (Omicron BA.5) in complex with PD of ACE2 |
Heteromer P0DTC2; | 100 | 38×NAG; 28×NAG; | |||
S-ECD (Omicron BA.2) in complex with PD of ACE2 |
Heteromer P0DTC2; | 100 | 38×NAG; 28×NAG; | |||
S-ECD (Omicron) in complex with PD of ACE2 |
Heteromer P0DTC2; | 100 | 23×NAG; 45×NAG; | |||
S-RBD (Omicron XBB.1) in complex with PD of ACE2 |
Heteromer P0DTC2; | 100 | 6×NAG; 1×NAG; | |||
SARS-CoV-2 Kappa variant spike protein in complex with ACE2, state C2a |
Heteromer P0DTC2; | 100 | ||||
Trypsin-cleaved and low pH-treated SARS-CoV spike glycoprotein and ACE2 complex, ACE2-bound conform… |
Heteromer P59594; | 100 | ||||
Trypsin-cleaved and low pH-treated SARS-CoV spike glycoprotein and ACE2 complex, ACE2-bound conform… |
Heteromer P59594; | 100 | ||||
Local map of Omicron Subvariant JN.1 RBD with ACE2 |
Heteromer P0DTC2; | 100 | ||||
Cryo-EM structure of the WIV1 S-hACE2 complex |
Heteromer U5WLK5; | 100 | 13×NAG; 3×NAG; 21×NAG; | |||
The structure of FC08 Fab-hA.CE2-RBD complex |
Heteromer P0DTC2; | 100 | 5×NAG; | |||
SARS-COV-2 Spike RBDMACSp6 binding to hACE2 |
Heteromer P0DTC2; | 100 | 5×NAG; | |||
Spike Trimer of BA.2.86 in complex with two hACE2s |
Heteromer P0DTC2; | 100 | 15×NAG; 41×NAG; 2×ZN; 2×CL; | |||
Spike Trimer of BA.2.86 in complex with one hACE2 |
Heteromer P0DTC2; | 100 | 17×NAG; 35×NAG; 1×ZN; 1×CL; | |||
S-RBD (Omicron BA.2.75) in complex with PD of ACE2 |
Heteromer P0DTC2; | 100 | 6×NAG; 1×NAG; | |||
The global map of Omicron Subvariants Spike with ACE2 |
Heteromer P0DTC2; | 100 | ||||
SARS-CoV-2 BA.2.75 S Trimer in complex with ACE2(state1) |
Heteromer P0DTC2; | 100 | 9×NAG; 1×ZN; 1×CL; 49×NAG; | |||
SARS-CoV-2 BA.2.75 S Trimer in complex with ACE2(state2) |
Heteromer P0DTC2; | 100 | 9×NAG; 53×NAG; 2×ZN; 2×CL; | |||
ACE2-RBD in SARS-CoV-2 Beta variant S-ACE2 complex |
Heteromer P0DTC2; | 100 | 1×ZN; 5×NAG; | |||
SARS-CoV-2 Kappa variant spike protein in C2b state |
Heteromer P0DTC2; | 100 | ||||
SARS-CoV-2 Kappa variant spike protein in C3 state |
Heteromer P0DTC2; | 100 | ||||
The structures of Ace2 in complex with bicyclic peptide inhibitor |
Heteromer | 100 | 1×ZN; 1×LFI; | |||
ACE2 in complex with bicyclic peptide inhibitor |
Heteromer | 100 | 1×LFI; | |||
The structures of Ace2 in complex with bicyclic peptide inhibitor |
Heteromer | 100 | 2×LFI; | |||
Crystal structure of chimeric omicron RBD (strain BA.2) complexed with human ACE2 |
Heteromer P0DTC2; | 100 | 2×NAG; 1×ZN; 1×CL; 5×NAG; 1×NA; | |||
Structure of SARS-CoV-2 spike receptor-binding domain Y453F mutation complexed with human ACE2 |
Heteromer P0DTC2; | 100 | 4×NAG; 1×ZN; | |||
SARS-CoV-2 spike receptor-binding domain with a G485R mutation in complex with human ACE2 |
Heteromer P0DTC2; | 100 | 1×NAG; 4×NAG; 3×EDO; 1×ZN; | |||
Structure of SARS-CoV-2 spike receptor-binding domain in complex with high affinity ACE2 mutant (T2… |
Heteromer P0DTC2; | 99.66 | 5×NAG; | |||
Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2 |
Heteromer P0DTC2; | 100 | 4×NAG; 1×ZN; | |||
Crystal structure of chimeric omicron RBD (strain BA.1) complexed with human ACE2 |
Heteromer | 100 | 2×NAG; 5×NAG; 1×ZN; 2×CL; | |||
Structure of SARS-CoV-2 Beta variant spike receptor-binding domain complexed with human ACE2 |
Heteromer P0DTC2; | 100 | 1×NAG; 5×NAG; 1×ZN; | |||
Structure of SARS-CoV-2 chimeric receptor-binding domain complexed with its receptor human ACE2 |
Heteromer P0DTC2; P59594; | 100 | 3×NAG; 2×NAG; 1×ZN; 1×CL; 1×EDO; 1×NAG; | |||
Structure of SARS-CoV-2 spike receptor-binding domain in complex with high affinity ACE2 mutant (S1… |
Heteromer P0DTC2; | 99.66 | 5×NAG; | |||
Crystal structure of Omicron BA.3 RBD complexed with hACE2 |
Heteromer P0DTC2; | 100 | 1×NAG; 1×NAG; 1×NAG; 1×ZN; 3×NAG; | |||
Structure of SARS-CoV-2 Gamma variant receptor-binding domain complexed with high affinity human AC… |
Heteromer P0DTC2; | 99.66 | 1×ZN; 1×NAG; | |||
Structure of SARS-CoV-2 spike receptor-binding domain F486L mutation complexed with human ACE2 |
Heteromer P0DTC2; | 100 | 4×NAG; 1×ZN; | |||
SARS-CoV-2 Beta RBD in complex with human ACE2 and S304 Fab and S309 Fab |
Heteromer P0DTC2; | 100.0 | 2×NAG; 30×EDO; 22×CL; 2×ZN; 13×NAG; | |||
Crystal structure of chimeric omicron RBD (strain XBB.1) complexed with human ACE2 |
Heteromer P59594; | 100 | 2×NAG; 3×NAG; 1×ZN; 1×CL; 1×EDO; 1×NAG; | |||
Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immuni… |
Heteromer P0DTC2; | 100.0 | 1×NAG; 8×CL; 1×SO4; 4×NA; 1×PG5; 1×ZN; 4×NAG; 1×PGE; | |||
Structure of SARS-CoV-2 Gamma variant spike receptor-binding domain complexed with human ACE2 |
Heteromer P0DTC2; | 100 | 1×NAG; 5×NAG; 1×ZN; | |||
Structure of SARS-CoV-2 Alpha variant spike receptor-binding domain complexed with human ACE2 |
Heteromer P0DTC2; | 100 | 1×NAG; 4×NAG; 1×ZN; | |||
SARS-CoV-2 Omicron BA.2.75 RBD in complex with ACE2 |
Heteromer P0DTC2; | 100 | 12×GOL; 6×NAG; 1×CL; 1×PGE; | |||
Crystal structure of Omicron BA.2 RBD complexed with hACE2 |
Heteromer P0DTC2; | 100 | 1×NAG; 2×NAG; 1×ZN; 3×NAG; | |||
Structure of SARS-CoV-2 Omicron BA.2.75 RBD in complex with human ACE2 |
Heteromer P0DTC2; | 100 | 1×NAG; 1×NAG; 1×ZN; 3×NAG; | |||
Crystal structure of human ACE2 bound to the spike receptor-binding domain from a cave bat sarbecov… |
Heteromer P0DTC2; | 100 | 1×NAG; 6×NAG; 4×SO4; 1×TRS; 5×PEG; 1×ZN; 2×CL; 1×GOL; | |||
Crystal structure of the receptor binding domain of SARS-CoV-2 Omicron variant spike glycoprotein i… |
Heteromer P0DTC2; | 100 | 1×NAG; 5×NAG; 1×ZN; | |||
Crystal structure of Omicron BA.1.1 RBD complexed with hACE2 |
Heteromer P0DTC2; | 100 | 6×NAG; 1×ZN; | |||
Crystal structure of chimeric omicron RBD (strain XBB.1.5) complexed with human ACE2 |
Heteromer P59594; | 100 | 2×NAG; 1×NAG; 1×ZN; 1×CL; 3×NAG; | |||
Structural basis of SARS-CoV-2-closely-related bat coronavirus RaTG13 to hACE2 |
Heteromer | 100 | 2×NAG; 4×NAG; 1×ZN; | |||
Crystal structure of the receptor binding domain of SARS-CoV-2 P.1 variant Spike glycoprotein in co… |
Heteromer P0DTC2; | 100 | 5×NAG; | |||
Crystal structure of NL63 respiratory coronavirus receptor-binding domain complexed with its human … |
Heteromer Q6Q1S2; | 100.0 | 8×NAG; | |||
Crystal structure of the receptor binding domain of SARS-CoV-2 Delta variant spike glycoprotein in … |
Heteromer P0DTC2; | 100 | 1×NAG; 1×NAG; 4×NAG; 1×ZN; | |||
Crystal structure of the receptor binding domain of SARS-CoV-2 Omicron BA.4/5 variant spike protein… |
Heteromer P0DTC2; | 100 | 2×NAG; 2×NAG; 1×ZN; 1×NAG; | |||
The crystal structure of RshSTT182/200 RBD-insert2-T346R-Y496G mutant in complex with human ACE2 |
Heteromer | 100 | 6×NAG; 1×ZN; | |||
Crystal structure of BF.7 RBD complexed with human ACE2 |
Heteromer P0DTC2; | 100 | 1×NAG; 1×ZN; 3×NAG; | |||
Crystal structure of BQ.1.1 RBD complexed with human ACE2 |
Heteromer P0DTC2; | 100 | 1×NAG; 1×ZN; 4×NAG; | |||
The complex structure of RshSTT182/200 RBD-insert2 bound to human ACE2 |
Heteromer | 100 | 6×NAG; 1×ZN; | |||
Cryo-EM structure of hACE2-bound SARS-CoV-2 Omicron spike protein with L371S, P373S and F375S mutat… |
Heteromer P0DTC2; | 100 | 1×NAG; 5×NAG; 1×ZN; | |||
Structure of SARS-CoV-2 XBB.1 spike RBD in complex with ACE2 |
Heteromer P0DTC2; | 100 | 2×NAG; 1×NAG; 1×NAG; 3×NAG; | |||
Cryo-EM structure of SARS-CoV-2 Alpha (B.1.1.7) spike protein in complex with human ACE2 (focused r… |
Heteromer P0DTC2; | 100 | 7×NAG; | |||
Cryo-EM structure of SARS-CoV-2 Gamma (P.1) spike protein in complex with human ACE2 (focused refin… |
Heteromer P0DTC2; | 100 | 7×NAG; | |||
Cryo-EM structure of SARS-CoV-2 Kappa (B.1.617.1) spike protein in complex with human ACE2 (focused… |
Heteromer P0DTC2; | 100 | 7×NAG; | |||
SARS-CoV-2 Omicron BQ.1 RBD complexed with human ACE2 |
Heteromer P0DTC2; | 100 | 1×NAG; 1×NAG; 5×NAG; 1×ZN; | |||
SARS-CoV-2 Omicron HV.1 RBD in complex with human ACE2 (local refinement from the spike protein) |
Heteromer P0DTC2; | 100 | 6×NAG; 1×ZN; | |||
Cryo-EM structure of SARS-CoV-2 Omicron BA.2.86 RBD in complex with human ACE2 |
Heteromer P0DTC2; | 100 | 2×NAG; 1×NAG; 1×ZN; 5×NAG; | |||
Locally refined SARS-CoV-2 BA-2.86 Spike receptor binding domain (RBD) complexed with angiotensin c… |
Heteromer P0DTC2; | 100 | 6×NAG; | |||
SARS-CoV-2 Omicron XBB RBD complexed with human ACE2 |
Heteromer P0DTC2; | 100 | 1×NAG; 6×NAG; 1×ZN; | |||
Structure of SARS-CoV-2 XBB.1.5 spike RBD in complex with ACE2 |
Heteromer P0DTC2; | 100 | 1×NAG; 1×NAG; 1×NAG; 4×NAG; | |||
Cryo-EM structure of the SARS-CoV-2 N501Y mutant spike protein ectodomain bound to human ACE2 ectod… |
Heteromer P0DTC2; | 100 | 5×NAG; | |||
Structure of the SARS-CoV-2 EG.5.1 spike RBD in complex with ACE2 |
Heteromer P0DTC2; | 100 | 2×NAG; 1×NAG; 1×NAG; 3×NAG; | |||
Cryo-EM structure of SARS-CoV-2 Beta (B.1.351) spike protein in complex with human ACE2 (focused re… |
Heteromer P0DTC2; | 100 | 7×NAG; | |||
Local refinement of SARS-CoV-2 S-Beta variant (B.1.351) RBD and Angiotensin-converting enzyme 2 (AC… |
Heteromer P0DTC2; | 100 | 3×NAG; 5×NAG; | |||
Cryo-EM structure of the SARS-CoV-2 D614G,N501Y,E484K,K417N mutant spike protein ectodomain bound t… |
Heteromer P0DTC2; | 100 | 7×NAG; | |||
Local refinement of SARS-CoV-2 S-Gamma variant (P.1) RBD and Angiotensin-converting enzyme 2 (ACE2)… |
Heteromer P0DTC2; | 100 | 5×NAG; 3×NAG; | |||
Cryo-EM structure of the SARS-CoV-2 D614G,N501Y mutant spike protein ectodomain bound to human ACE2… |
Heteromer P0DTC2; | 100 | 7×NAG; | |||
Cryo-EM structure of SARS-CoV-2 Omicron JN.1 RBD in complex with human ACE2 (local refinement from … |
Heteromer P0DTC2; | 100 | 2×NAG; 3×NAG; 1×ZN; 3×NAG; | |||
Cryo-EM structure of the SARS-CoV-2 D614G mutant spike protein ectodomain bound to human ACE2 ectod… |
Heteromer P0DTC2; | 100 | 7×NAG; | |||
ACE2-RBD Focused Refinement Using Symmetry Expansion of Applied C3 for Triple ACE2-bound SARS-CoV-2… |
Heteromer P0DTC2; | 100 | 2×NAG; 5×NAG; | |||
Cryo-EM structure of the SARS-CoV-2 D614G,N501Y,E484K,K417T mutant spike protein ectodomain bound t… |
Heteromer P0DTC2; | 100 | 7×NAG; | |||
SARS-CoV-2 Omicron EG.5.1 RBD in complex with human ACE2 (local refined from the spike protein) |
Heteromer P0DTC2; | 100 | 1×NAG; 5×NAG; 1×ZN; | |||
Cryo-EM structure of the SARS-CoV-2 D614G,N501Y,E484K mutant spike protein ectodomain bound to huma… |
Heteromer P0DTC2; | 100 | 7×NAG; | |||
Local refinement of SARS-CoV-2 S-Delta variant (B.1.617.2) RBD and Angiotensin-converting enzyme 2 … |
Heteromer P0DTC2; | 100 | 1×NAG; 4×NAG; 3×NAG; | |||
Cryo-EM structure of SARS-CoV-2 Omicron BA.2 RBD in complex with human ACE2 (local refinement) |
Heteromer P0DTC2; | 100 | 1×ZN; 7×NAG; | |||
SARS-CoV-2 Omicron BQ.1.1 RBD complexed with human ACE2 |
Heteromer P0DTC2; | 100 | 1×NAG; 1×NAG; 5×NAG; 1×ZN; | |||
Local refinement of SARS-CoV-2 S-Kappa variant (B.1.617.1) RBD and Angiotensin-converting enzyme 2 … |
Heteromer P0DTC2; | 100 | 2×NAG; 1×NAG; 4×NAG; | |||
Cryo-EM structure of human ACE2 complexed with SARS-CoV-2 Omicron RBD |
Heteromer P0DTC2; | 100 | 4×NAG; 1×ZN; | |||
Cryo-EM structure of SARS-CoV-2 Omicron BA.4/5 RBD in complex with human ACE2 (local refinement) |
Heteromer P0DTC2; | 100 | 1×NAG; 1×NAG; 5×NAG; 1×ZN; | |||
SARS-CoV-2 Omicron BF.7 RBD complexed with human ACE2 |
Heteromer P0DTC2; | 100 | 1×NAG; 1×NAG; 5×NAG; 1×ZN; | |||
Cryo-EM structure of the SARS-CoV-2 D614G,L452R mutant spike protein ectodomain bound to human ACE2… |
Heteromer P0DTC2; | 100 | 7×NAG; | |||
Cryo-EM structure of SARS-CoV-2 Epsilon (B.1.429) spike protein in complex with human ACE2 (focused… |
Heteromer P0DTC2; | 100 | 7×NAG; | |||
Cryo-EM structure of SARS-CoV-2 Delta (B.1.617.2) spike protein in complex with human ACE2 (focused… |
Heteromer P0DTC2; | 100 | 7×NAG; | |||
Local refinement of RBD-ACE2 |
Heteromer P0DTC2; | 100 | 1×NAG; 6×NAG; 1×ZN; | |||
Cryo-EM structure of SARS-CoV-2 Omicron RBD in complex with human ACE2 ectodomain (local refinement) |
Heteromer P0DTC2; | 100 | 1×NAG; 1×ZN; 6×NAG; | |||
Cryo-EM structure of SARS-CoV-2 S-Gamma variant (P.1) in complex with Angiotensin-converting enzyme… |
Heteromer P0DTC2; | 100 | 30×NAG; 1×NAG; 19×NAG; | |||
BA.2(S375) Spike (S6P)/hACE2 complex |
Heteromer P0DTC2; | 100 | 3×NAG; 51×NAG; | |||
Cryo-EM structure of the SARS-CoV-2 D614G,N501Y,E484K mutant spike protein ectodomain bound to huma… |
Heteromer P0DTC2; | 100 | 18×NAG; 26×NAG; | |||
Cryo-EM structure of SARS-CoV-2 Alpha (B.1.1.7) spike protein in complex with human ACE2 |
Heteromer P0DTC2; | 100 | 18×NAG; 28×NAG; | |||
Cryo-EM structure of SARS-CoV-2 S-Delta variant (B.1.617.2) in complex with Angiotensin-converting … |
Heteromer P0DTC2; | 100 | 43×NAG; 14×NAG; | |||
Cryo-EM structure of SARS-CoV-2 Epsilon (B.1.429) spike protein in complex with human ACE2 |
Heteromer P0DTC2; | 100 | 18×NAG; 36×NAG; | |||
Cryo-EM Structure of Double ACE2-Bound SARS-CoV-2 Trimer Spike at pH 5.5 |
Heteromer P0DTC2; | 100 | 4×NAG; 48×NAG; | |||
Cryo-EM structure of SARS-CoV-2 S-Gamma variant (P.1) in complex with Angiotensin-converting enzyme… |
Heteromer P0DTC2; | 100 | 29×NAG; 26×NAG; | |||
Cryo-EM structure of Triple ACE2-bound SARS-CoV-2 Trimer Spike at pH 5.5 |
Heteromer P0DTC2; | 100 | 6×NAG; 56×NAG; | |||
Cryo-EM structure of the SARS-CoV-2 N501Y mutant spike protein ectodomain bound to human ACE2 ectod… |
Heteromer P0DTC2; | 100 | 18×NAG; 32×NAG; | |||
Cryo-EM structure of triple ACE2-bound SARS-CoV-2 trimer spike at pH 7.4 |
Heteromer P0DTC2; | 100 | 8×NAG; 55×NAG; | |||
Cryo-EM structure of SARS-CoV-2 Kappa (B.1.617.1) spike protein in complex with human ACE2 |
Heteromer P0DTC2; | 100 | 18×NAG; 26×NAG; | |||
Structure of SARS-CoV-2 XBB.1 spike glycoprotein in complex with ACE2 (1-up state) |
Heteromer P0DTC2; | 100 | 8×NAG; 1×NAG; 1×NAG; 36×NAG; | |||
Cryo-EM structure of SARS-CoV-2 Omicron JN.1 spike protein in complex with human ACE2 |
Heteromer P0DTC2; | 100 | 6×NAG; 13×NAG; 3×ZN; 37×NAG; | |||
Cryo-EM structure of SARS-CoV-2 S-Beta variant (B.1.351) in complex with Angiotensin-converting enz… |
Heteromer P0DTC2; | 100 | 31×NAG; 17×NAG; | |||
Cryo-EM structure of SARS-CoV-2 Omicron spike protein (S-6P-RRAR) in complex with human ACE2 ectodo… |
Heteromer P0DTC2; | 100 | 22×NAG; 23×NAG; 1×ZN; | |||
Cryo-EM structure of SARS-CoV-2 Omicron HV.1 spike protein(6P) in complex with human ACE2 |
Heteromer P0DTC2; | 100 | 29×NAG; 1×ZN; | |||
Cryo-EM structure of SARS-CoV-2 S-Delta variant (B.1.617.2) in complex with Angiotensin-converting … |
Heteromer P0DTC2; | 100 | 37×NAG; 15×NAG; | |||
Structure of the SARS-CoV-2 EG.5.1 spike glycoprotein in complex with ACE2 (1-up state) |
Heteromer P0DTC2; | 100 | 8×NAG; 1×NAG; 1×NAG; 33×NAG; | |||
Cryo-EM structure of SARS-CoV-2 Beta (B.1.351) spike protein in complex with human ACE2 |
Heteromer P0DTC2; | 100 | 18×NAG; 26×NAG; | |||
Cryo-EM structure of single ACE2-bound SARS-CoV-2 trimer spike at pH 5.5 |
Heteromer P0DTC2; | 100 | 6×NAG; 44×NAG; | |||
Cryo-EM structure of SARS-CoV-2 Gamma (P.1) spike protein in complex with human ACE2 |
Heteromer P0DTC2; | 100 | 18×NAG; 42×NAG; | |||
Cryo-EM structure of the SARS-CoV-2 D614G,N501Y mutant spike protein ectodomain bound to human ACE2… |
Heteromer P0DTC2; | 100 | 18×NAG; 28×NAG; | |||
Cryo-EM structure of hACE2-bound SARS-CoV-2 Omicron spike protein with L371S, P373S and F375S mutat… |
Heteromer P0DTC2; | 100 | 15×NAG; 33×NAG; 3×ZN; | |||
Structure of SARS-CoV-2 XBB.1.5 spike glycoprotein in complex with ACE2 (1-up state) |
Heteromer P0DTC2; | 100 | 8×NAG; 1×NAG; 1×NAG; 35×NAG; | |||
Cryo-EM structure of the SARS-CoV-2 D614G,N501Y,E484K,K417T mutant spike protein ectodomain bound t… |
Heteromer P0DTC2; | 100 | 18×NAG; 28×NAG; | |||
Cryo-EM structure of SARS-CoV-2 Omicron BA.2.86 spike protein(6P) in complex with human ACE2 |
Heteromer P0DTC2; | 100 | 1×NAG; 5×NAG; 1×ZN; 33×NAG; | |||
Cryo-EM structure of double ACE2-bound SARS-CoV-2 trimer Spike at pH 7.4 |
Heteromer P0DTC2; | 100 | 4×NAG; 53×NAG; | |||
Cryo-EM structure of single ACE2-bound SARS-CoV-2 trimer spike at pH 7.4 |
Heteromer P0DTC2; | 100 | 5×NAG; 46×NAG; | |||
Cryo-EM structure of SARS-CoV-2 S-Delta variant (B.1.617.2) in complex with Angiotensin-converting … |
Heteromer P0DTC2; | 100 | 38×NAG; 16×NAG; | |||
Cryo-EM structure of SARS-CoV-2 S-Kappa variant (B.1.617.1) in complex with Angiotensin-converting … |
Heteromer P0DTC2; | 100 | 31×NAG; 13×NAG; | |||
Structure of SARS-CoV-2 XBB.1.5 spike glycoprotein in complex with ACE2 (2-up state) |
Heteromer P0DTC2; | 100 | 9×NAG; 2×NAG; 2×NAG; 42×NAG; | |||
Cryo-EM structure of the SARS-CoV-2 D614G mutant spike protein ectodomain bound to human ACE2 ectod… |
Heteromer P0DTC2; | 100 | 18×NAG; 26×NAG; | |||
Cryo-EM structure of SARS-CoV-2 S-Kappa variant (B.1.617.1) in complex with Angiotensin-converting … |
Heteromer P0DTC2; | 100 | 37×NAG; 13×NAG; | |||
Cryo-EM structure of SARS-CoV-2 Omicron EG.5.1 spike protein(6P) in complex with human ACE2 |
Heteromer P0DTC2; | 100 | 36×NAG; 1×ZN; | |||
Cryo-EM structure of the SARS-CoV-2 D614G,N501Y,E484K,K417N mutant spike protein ectodomain bound t… |
Heteromer P0DTC2; | 100 | 18×NAG; 42×NAG; | |||
Cryo-EM structure of SARS-CoV-2 S-Gamma variant (P.1) in complex with Angiotensin-converting enzyme… |
Heteromer P0DTC2; | 100 | 30×NAG; 29×NAG; | |||
Cryo-EM structure of SARS-CoV-2 Delta (B.1.617.2) spike protein in complex with human ACE2 |
Heteromer P0DTC2; | 100 | 18×NAG; 26×NAG; | |||
Cryo-EM structure of the SARS-CoV-2 D614G,L452R mutant spike protein ectodomain bound to human ACE2… |
Heteromer P0DTC2; | 100 | 18×NAG; 28×NAG; | |||
Cryo-EM structure of SARS-CoV-2 Omicron spike protein (S-6P-RRAR) in complex with human ACE2 ectodo… |
Heteromer P0DTC2; | 100 | 23×NAG; 24×NAG; 2×ZN; | |||
Cryo-EM structure of SARS-CoV-2 S-UK variant (B.1.1.7) in complex with Angiotensin-converting enzym… |
Heteromer P0DTC2; | 100 | 29×NAG; 26×NAG; | |||
SARS-CoV-2 Spike (6P) in complex with 3 R1-32 Fabs and 3 ACE2, focused refinement of RBD region |
Heteromer P0DTC2; | 100 | 1×ZN; 4×NAG; | |||
Cryo-EM structure of Omicron RBD complexed with ACE2 and 304 Fab |
Heteromer P0DTC2; | 100 | 1×NAG; 5×NAG; 1×ZN; | |||
SARS-CoV-2 Omicron XBB.1.5 RBD complexed with human ACE2 and S304 |
Heteromer P0DTC2; | 100 | 1×NAG; 1×NAG; 5×NAG; 1×ZN; | |||
SARS-CoV-2 RBD + IMCAS-364 + hACE2 |
Heteromer P0DTC2; | 100 | 4×NAG; 1×ZN; | |||
Structure of SARS-CoV-2 BA.2.86 spike glycoprotein in complex with ACE2 (3-up state) |
Heteromer P0DTC2; | 100 | 6×NAG; 3×NAG; 3×NAG; 45×NAG; | |||
Structure of SARS-CoV-2 BA.2.86 spike glycoprotein in complex with ACE2 (2-up state) |
Heteromer P0DTC2; | 100 | 10×NAG; 2×NAG; 2×NAG; 38×NAG; | |||
Structure of SARS-CoV-2 BA.2.86 spike RBD in complex with ACE2 (up state) |
Heteromer P0DTC2; | 100 | 2×NAG; 1×NAG; 1×NAG; 4×NAG; | |||
Structure of SARS-CoV-2 BA.2.86 spike glycoprotein in complex with ACE2 (2-up and 1-down state) |
Heteromer P0DTC2; | 100 | 7×NAG; 2×NAG; 1×NAG; 1×NAG; 32×NAG; | |||
Structure of SARS-CoV-2 BA.2.86 spike RBD in complex with ACE2 (down state) |
Heteromer P0DTC2; | 100 | 1×NAG; 1×NAG; 1×NAG; 5×NAG; | |||
Structure of SARS-CoV-2 JN.1 spike RBD in complex with ACE2 (up state) |
Heteromer P0DTC2; | 100 | 2×NAG; 1×NAG; 1×NAG; 2×NAG; | |||
Cryo-EM structure of SARS-CoV-2 Omicron BA.2.12.1 RBD in complex with human ACE2 (local refinement) |
Heteromer P0DTC2; | 100 | 1×NAG; 1×NAG; 5×NAG; 1×ZN; | |||
SARS-CoV-2 Spike (6P) in complex with 3 R1-32 Fabs and 3 ACE2 |
Heteromer P0DTC2; | 100 | 6×NAG; 36×NAG; 3×ZN; | |||
SARS-CoV-2 Omicron BA.4 RBD + IMCAS-316 + ACE2 |
Heteromer P0DTC2; | 100 | 1×NAG; 6×NAG; 1×ZN; | |||
the structure of BtSY1_RBD/hACE2 protein |
Heteromer U5WLK5; | 100 | 1×NAG; 5×NAG; 1×ZN; | |||
The structures of Ace2 in complex with bicyclic peptide inhibitor |
Heteromer | 100 | 2×ZN; 1×LFI; | |||
Crystal structure of the receptor binding domain of SARS-CoV-2 Omicron BQ.1.1 variant spike protein… |
Heteromer P0DTC2; | 100 | 3×NAG; 1×NAG; 1×NAG; 1×ZN; 1×NAG; | |||
Crystal structure of chimeric omicron RBD (strain BA.2) complexed with chimeric mouse ACE2 |
Heteromer P0DTC2; | 95.46 | 1×NAG; 1×ZN; 1×CL; 3×NAG; 5×EDO; | |||
SARS-CoV-2 Omicron RBD in complex with human ACE2 and S304 Fab and S309 Fab |
Heteromer P0DTC2; | 100.0 | 4×EDO; 11×CL; 1×ZN; 6×NAG; | |||
SARS-CoV-2 Wuhan-hu-1-Spike-RBD bound to computationally engineered ACE2 mimetic CVD293 |
Heteromer P0DTC2; | 99.5 | 7×NAG; | |||
BA.4/5 SARS-CoV-2 Spike bound to human ACE2 (local) |
Heteromer P0DTC2; | 100 | 6×NAG; 1×ZN; | |||
SARS-CoV-2 Omicron BA.2 Variant RBD complexed with human ACE2 |
Heteromer P0DTC2; | 100 | 1×CL; 1×ZN; 3×NAG; | |||
Structures of Omicron Spike complexes illuminate broad-spectrum neutralizing antibody development |
Heteromer P0DTC2; | 100 | 7×NAG; | |||
Cryo-EM structure of SARS-CoV-2 Omicron BA.2 spike protein in complex with human ACE2 (focused refi… |
Heteromer P0DTC2; | 100 | 7×NAG; | |||
SARS-CoV-2 Omicron Variant RBD complexed with ACE2 |
Heteromer P0DTC2; | 100 | 3×NAG; 1×CL; 1×ZN; | |||
Cryo-EM structure of SARS-CoV-2 Omicron spike protein in complex with human ACE2 (focused refinemen… |
Heteromer P0DTC2; | 100 | 7×NAG; | |||
SARS-CoV-2 Wuhan-hu-1-Spike-RBD bound to linker variant of affinity matured ACE2 mimetic CVD432 |
Heteromer P0DTC2; | 99.33 | 7×NAG; | |||
Dissociated S1 domain of SARS-CoV-2 Spike bound to ACE2 (Non-Uniform Refinement) |
Heteromer P0DTC2; | 100.0 | 1×NAG; 7×NAG; 1×ZN; | |||
Trypsin-digested S protein of SARS-CoV-2 bound with PD of ACE2 in the conformation 2 (2 up RBD and … |
Heteromer P0DTC2; | 100 | 32×NAG; 29×NAG; | |||
The second RBD of SARS-CoV-2 Omicron Variant in complexed with RBD-ACE2 |
Heteromer P0DTC2; | 100 | 2×NAG; 1×CL; 1×ZN; 3×NAG; | |||
Furin Cleaved Alpha Variant SARS-CoV-2 Spike in complex with 3 ACE2 |
Heteromer P0DTC2; | 100.0 | 3×NAG; 48×NAG; 3×ZN; | |||
Dissociated S1 domain of SARS-CoV-2 Spike bound to ACE2 (Unmasked Refinement) |
Heteromer P0DTC2; | 100.0 | 1×NAG; 7×NAG; 1×ZN; | |||
SARS-CoV-2 B.1.1.7 S-ACE2 complex |
Heteromer P0DTC2; | 100.0 | 16×NAG; 27×NAG; | |||
Cryo-EM structure of SARS-CoV-2 XBB.1.5 spike protein in complex with human ACE2 |
Heteromer P0DTC2; | 100 | 24×NAG; 33×NAG; | |||
SARS-CoV-2 Omicron BA.2 Variant Spike Trimer with three human ACE2 Bound |
Heteromer P0DTC2; | 100 | 39×NAG; 3×CL; 3×ZN; | |||
SARS-CoV-2 Spike Glycoprotein with 2 ACE2 Bound |
Heteromer P0DTC2; | 100.0 | ||||
SARS-CoV-2 Spike Glycoprotein with 3 ACE2 Bound |
Heteromer P0DTC2; | 100.0 | ||||
Dissociated S1 domain of Mink Variant SARS-CoV-2 Spike bound to ACE2 (Non-Uniform Refinement) |
Heteromer P0DTC2; | 100.0 | 1×ZN; 6×NAG; | |||
S protein of SARS-CoV-2 bound with PD of ACE2 in the conformation 3 (2 up RBD and 1 PD bound) |
Heteromer P0DTC2; | 100 | 27×NAG; 28×NAG; | |||
Cryo-EM structure of SARS-CoV-2 Omicron BA.2 spike protein in complex with human ACE2 |
Heteromer P0DTC2; | 100 | 18×NAG; 33×NAG; | |||
SARS-CoV-2 Spike Glycoprotein with 1 ACE2 Bound |
Heteromer P0DTC2; | 100.0 | 23×NAG; 1×ZN; | |||
SARS-CoV-2 Omicron Variant SPIKE trimer complexed with ACE2 |
Heteromer P0DTC2; | 100 | 12×NAG; 21×NAG; 1×CL; 1×ZN; | |||
Trypsin-digested S protein of SARS-CoV-2 bound with PD of ACE2 in the conformation 1 (1 up RBD and … |
Heteromer P0DTC2; | 100 | 27×NAG; 28×NAG; | |||
SARS-CoV-2 Spike Glycoprotein with 1 ACE2 Bound and 1 RBD Erect in Clockwise Direction |
Heteromer P0DTC2; | 100.0 | ||||
Dissociated S1 domain of Alpha Variant SARS-CoV-2 Spike bound to ACE2 |
Heteromer P0DTC2; | 100.0 | 1×ZN; 7×NAG; | |||
Structures of Omicron Spike complexes illuminate broad-spectrum neutralizing antibody development |
Heteromer P0DTC2; | 100 | 14×NAG; 20×NAG; | |||
Dissociated S1 domain of Alpha Variant SARS-CoV-2 Spike bound to ACE2 (Non-Uniform Refinement) |
Heteromer P0DTC2; | 100.0 | 1×ZN; 8×NAG; | |||
SARS-CoV-2 Omicron BA.2 Variant Spike Trimer with two human ACE2 Bound |
Heteromer P0DTC2; | 100 | 39×NAG; 2×CL; 2×ZN; | |||
SARS-CoV-2 Spike Glycoprotein with 1 ACE2 Bound and 1 RBD Erect in Anticlockwise Direction |
Heteromer P0DTC2; | 100.0 | ||||
Structures of Omicron Spike complexes illuminate broad-spectrum neutralizing antibody development |
Heteromer P0DTC2; | 100 | 14×NAG; 12×NAG; | |||
Trypsin-digested S protein of SARS-CoV-2 bound with PD of ACE2 in the conformation 3 (3 up RBD and … |
Heteromer P0DTC2; | 100 | 32×NAG; 29×NAG; | |||
S protein of SARS-CoV-2 in complex bound with T-ACE2 |
Heteromer P0DTC2; | 100 | 35×NAG; 34×NAG; | |||
S protein of SARS-CoV-2 bound with PD of ACE2 in the conformation 2 (1 up RBD and 1 PD bound) |
Heteromer P0DTC2; | 100 | 26×NAG; 30×NAG; | |||
Cryo-EM structure of SARS-CoV-2 Omicron spike protein in complex with human ACE2 |
Heteromer P0DTC2; | 100 | 18×NAG; 34×NAG; | |||
SARS-CoV-2 RBD-62 in complex with ACE2 peptidase domain |
Heteromer P0DTC2; | 100.0 | 1×ZN; 3×NAG; | |||
Cryo-EM structure of SARS-CoV-2 XBB.1.5 spike protein in complex with human ACE2 (focused refinemen… |
Heteromer P0DTC2; | 100 | 2×NAG; 5×NAG; | |||
SARS-CoV-2 BQ.1.1 spike RBD bound to the human ACE2 ectodomain and the S309 neutralizing antibody F… |
Heteromer P0DTC2; | 100.0 | 1×NAG; 5×NAG; 1×ZN; | |||
Neutral Omicron Spike Trimer in complex with ACE2. |
Heteromer P0DTC2; | 100 | 5×NAG; | |||
XBB.1.5 RBD in complex with ACE2 |
Heteromer P0DTC2; | 100 | 5×NAG; | |||
SARS-COV-2 Spike RBDMACSp36 binding to hACE2 |
Heteromer P0DTC2; | 100 | 5×NAG; | |||
Neutral Omicron Spike Trimer in complex with ACE2 |
Heteromer P0DTC2; | 100 | 16×NAG; 5×NAG; 34×NAG; | |||
XBB.1.5.10 spike protein in complex with ACE2 |
Heteromer P0DTC2; | 100 | ||||
XBB.1.5 spike protein in complex with ACE2 |
Heteromer P0DTC2; | 100 | ||||
XBB.1.5.70 spike protein in complex with ACE2 |
Heteromer P0DTC2; | 100 | ||||
Dissociated S1 domain of Beta Variant SARS-CoV-2 Spike bound to ACE2 (Non-Uniform Refinement) |
Heteromer P0DTC2; | 100.0 | 7×NAG; 1×ZN; | |||
SARS-CoV-2 XBB.1 spike RBD bound to the human ACE2 ectodomain and the S309 neutralizing antibody Fa… |
Heteromer P0DTC2; | 100.0 | 1×NAG; 5×NAG; | |||
XBB.1.5.10 RBD in complex with ACE2 |
Heteromer P0DTC2; | 100 | 4×NAG; | |||
SARS-CoV-2 XBB.1.5.70 in complex with ACE2 |
Heteromer P0DTC2; | 100 | 4×NAG; | |||
SARS-CoV-2 Spike Glycoprotein with one ACE2 Bound |
Heteromer P0DTC2; | 100 | 17×NAG; 36×NAG; | |||
SARS-CoV-2 Spike Glycoprotein with two ACE2 Bound |
Heteromer P0DTC2; | 100 | 20×NAG; 40×NAG; | |||
SARS-CoV-2 Spike Glycoprotein with three ACE2 Bound |
Heteromer P0DTC2; | 100 | 24×NAG; 42×NAG; | |||
SARS-CoV-2 BA.2.75 S Trimer in complex with ACE2(interface) |
Heteromer P0DTC2; | 100 | ||||
The co-crystal structure of ACE2 with Fab |
Heteromer | 100.0 | 1×ZN; | |||
Cryo-EM structure of SARS-CoV-2 Omicron BA.2.86 RBD in complex with human ACE2 and S309 Fab |
Heteromer P0DTC2; | 100 | 1×NAG; 2×NAG; 1×NAG; 3×NAG; 1×ZN; | |||
Cryo-EM structure of SARS-CoV-2 Omicron spike protein with ACE2, C1 state |
Heteromer P0DTC2; | 100 | ||||
SARS-CoV-2 BN.1 spike RBD bound to the human ACE2 ectodomain and the S309 neutralizing antibody Fab… |
Heteromer P0DTC2; | 100.0 | 1×NAG; 5×NAG; | |||
Fab M2-7 complexed with SARS-Cov2 RBD and human ACE2 |
Heteromer P0DTC2; | 100.0 | 1×ZN; 3×NAG; | |||
Crystal structure of spike protein receptor-binding domain from the 2002-2003 SARS coronavirus huma… |
Heteromer P59594; Q56NL1; | 100 | 5×NDG; 2×ZN; 2×CL; 1×NAG; | |||
Crystal structure of spike protein receptor-binding domain from the 2005-2006 SARS coronavirus cive… |
Heteromer P59594; Q56NL1; | 100 | 5×NDG; 2×ZN; 2×CL; 1×NAG; | |||
Crystal structure of spike protein receptor-binding domain from SARS coronavirus epidemic strain co… |
Heteromer P59594; Q56NL1; | 100 | 1×ZN; 1×CL; | |||
Crystal structure of chimeric SARS-CoV-2 RBD complexed with chimeric raccoon dog ACE2 |
Heteromer B4XEP4; P0DTC2; | 100 | 1×NAG; 1×NAG; 1×NAG; 1×NAG; 1×ZN; 1×CL; 1×NAG; | |||
Crystal structure of chimeric bat coronavirus BANAL-20-236 RBD complexed with chimeric mouse ACE2 |
Heteromer Q8R0I0; | 100 | 1×NAG; 1×ZN; 1×CL; 5×EDO; 1×NAG; 1×NA; | |||
Crystal structure of chimeric RaTG13 RBD complexed with chimeric mouse ACE2 |
Heteromer Q8R0I0; | 100 | 1×NAG; 1×ZN; 1×CL; 1×EDO; 1×NAG; | |||
SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles |
Heteromer P59594; | 100 | 9×NAG; 7×NAG; 11×NAG; 6×NAG; | |||
Structure of human SIT1 bound to L-pipecolate (focussed map / refinement) |
Heteromer Q9NP91; | 100 | 2×NAG; 1×YCP; 1×CL; | |||
Structure of human SIT1 (focussed map / refinement) |
Heteromer Q9NP91; | 100 | 2×NAG; | |||
Importin alpha bound to the C-terminus of ACE2 |
Heteromer P52293; | 100 | ||||
Structure of human ACE2 in complex with a fluorinated small molecule inhibitor | monomer | 100.0 | 1×A1IDX; 3×NAG; 5×EDO; 1×CL; 1×NA; 1×ZN; | |||
ACE2-peptide 2 complex | monomer | 100.0 | 1×NAG; 1×NAG; 3×GOL; 1×NAG; 1×CL; 1×ZN; | |||
ACE2-peptide 1 complex | monomer | 100.0 | 3×NAG; 1×ZN; 1×CL; | |||
ACE2-peptide 2 complex crystal form 3 | monomer | 100 | 1×NAG; 3×NAG; 1×ZN; 1×CL; | |||
Cryo-EM structure of ACE2 | monomer | 100 | ||||
Cryo-EM structure of ACE2 | monomer | 100 | ||||
Cryo-EM structure of apo-state huamn angiotensin-converting enzyme 2 (ACE2) | monomer | 100 | ||||
ACE2-peptide 6 complex | monomer | 100.0 | 2×NAG; 5×GOL; 1×NAG; 1×ZN; 1×CL; | |||
ACE2-peptide2 complex crystal form 2 | monomer | 100 | 3×NAG; 1×ZN; 2×NAG; 1×CL; | |||
NMR structure of human ACE2 21-42 fragment in HFIP/water 50/50 v/v | monomer | 100 | ||||
3 SWISS-MODEL models
Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
---|---|---|---|---|---|---|
6m17.1.B | monomer | 0.84 | 1×NAG; 1×ZN; | 100.00 | ||
7mjm.1 |
Heteromer Q9BYF1; P0DTC2; | 0.77 | 99.45 | |||
7kj2.1 |
Heteromer P0DTC2; | 0.72 | 4×NAG; 10×NAG; | 99.67 | ||
1 SWISS-MODEL model built on isoform sequence
Isoform | Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
---|---|---|---|---|---|---|---|
Isoform 3 | 8p2y.1.A | monomer | 0.78 | 1×ZN; | 99.12 | ||